SCHEMBL5544830

SCHEMBL5544830

N=C(N)NNCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692743 0.79
SCHEMBL501327 0.76 LDHA (0.35)
SCHEMBL4737041 0.76 ITGB3 (0.36)
SCHEMBL349500 0.76
SCHEMBL22046339 0.76
SCHEMBL38656309 0.75
SCHEMBL17234578 0.75 TET2 (0.39)
Guanidino Acetate SCHEMBL33970 0.74
Guanidino Acetate SCHEMBL27413696 0.74 EGLN1 (0.41)
SCHEMBL9539681 0.73 LMNA (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1097580-C Aminoguanidine carboxylates for the treatment of non-insulin dependent diabetes mellitus BIOVITRUM AB (SE) 2003-01-01 CN claimed
EP-0793646-B1 AMINOGUANIDINE CARBOXYLATES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS UPJOHN CO (US) 2001-09-05 EP claimed
US-6166080-A Aminoquanidine carboxylates for the treatment of obesity PHARMACIA (US) 2000-12-26 US claimed
US-5994577-A Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus PHARMACIA & UPJOHN COMPANY 1999-11-30 US claimed
CN-1164226-A Aminoguanidine carboxylates for the treatment of non-insulin dependent diabetes mellitus UPJOHN CO (US) 1997-11-05 CN claimed
EP-0793646-A1 AMINOGUANIDINE CARBOXYLATES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS PHARMACIA &amp; UPJOHN COMPANY (US) 1997-09-10 EP claimed
WO-1996016031-A1 AMINOGUANIDINE CARBOXYLATES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS PHARMACIA & UPJOHN COMPANY (US) 1996-05-30 WO claimed
CN-118401120-A Application of guanidinoacetic acid in low-energy feed for pigs during fattening period 澳泽化学特罗斯特贝格有限公司 2024-07-26 CN disclosed
US-20240180912-A1 COMPOSITIONS AND METHODS FOR INHIBITING CREATINE TRANSPORT AS A TREATMENT FOR CANCER INSPIRNA, INC. (US) 2024-06-06 US disclosed
CN-116709928-A Use of feed additives in poultry low protein feed 澳泽化学特罗斯特贝格有限公司 2023-09-05 CN disclosed
CN-116437814-A Coating composition for bioactive components for oral administration to ruminants 赢创运营有限公司 2023-07-14 CN disclosed
WO-2023004308-A1 COMPOSITIONS AND METHODS FOR INHIBITING CREATINE TRANSPORT AS A TREATMENT FOR CANCER INSPIRNA, INC. (US) 2023-01-26 WO disclosed
EP-3950673-A1 INHIBITORS OF CREATINE TRANSPORT AND USES THEREOF Inspirna, Inc. (US) 2022-02-09 EP disclosed
EP-0793646-B1 AMINOGUANIDINE CARBOXYLATES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS UPJOHN CO (US) 2001-09-05 EP disclosed
US-6169115-B1 SUBSTRATES OR SUBSTRATE ANALOGS FOR CREATINE KINASE; KADDURAH-DAOUK RIMA (US) 2001-01-02 US disclosed
US-6166080-A Aminoquanidine carboxylates for the treatment of obesity PHARMACIA (US) 2000-12-26 US disclosed
US-5994577-A Aminoguanidine carboxylates for the treatment of non-insulin-dependent diabetes mellitus PHARMACIA & UPJOHN COMPANY 1999-11-30 US disclosed
CN-1164226-A Aminoguanidine carboxylates for the treatment of non-insulin dependent diabetes mellitus UPJOHN CO (US) 1997-11-05 CN disclosed
EP-0793646-A1 AMINOGUANIDINE CARBOXYLATES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS PHARMACIA &amp; UPJOHN COMPANY (US) 1997-09-10 EP disclosed
WO-1996016031-A1 AMINOGUANIDINE CARBOXYLATES FOR THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETES MELLITUS PHARMACIA & UPJOHN COMPANY (US) 1996-05-30 WO disclosed